II-VI Purchase Offer for Coherent Magnifies Differences, Similarities in Three Existing Bids - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    II-VI Purchase Offer for Coherent Magnifies Differences, Similarities in Three Existing Bids

    Article obtained from Photonics RSS Feed.

    Analysts and those from across the photonics landscape were digesting news of MKS Instruments’ $6 billion bid to acquire Coherent early last week — a move that itself countered a $5.7 billion deal that Lumentum in January struck to acquire Coherent — as optical components and semiconductor materials manufacturer II-VI released its second quarter fiscal year 2021 financial earnings. II-VI, on Tuesday, Feb. 9, reported record quarterly revenue of more than $785 million. The company also announced record cash from operations of more than $220 million, and record free cash flow of more than $175 million.

    Three days later, on Friday, Feb. 12, II-VI issued its own bid to acquire Coherent. The company’s offer, worth…

    READ MORE
    Feb, 16 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.